Skip to main content

Tumor Viability Assessed by Cerebral Blood Volume Measurements

  • Conference paper
Functional MRI

Part of the book series: Syllabus ((SYLLABUS))

  • 121 Accesses

Abstract

A common clinical problem in neuroradiology is the differentiation of recurrent malignant glioma from radiation necrosis. Frequently, patients present one to two years after surgery and radiation therapy with large intracranial lesions. The lesions enhance with intravenous contrast material and have associated vasogenic edema. It is virtually impossible to distinguish recurrent tumor from radiation necrosis based solely on the imaging characteristics. Previous studies using positron emission tomography (PET) and fluorodeoxyglucose (FDG) have been successful in differentiating these entities based on variations in metabolic activity [1–3].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. DiChiro G, Oldfield E, Wright DC, DeMichele D, Katz DA, Patronas NJ, Doppman JL, Larson SM, Ito M, Kufta CV (1988) Cerebral Necrosis After Radiotherapy and/or Intraarterial Chemotherapy for Brain Tumors: PET and Neuropathologic Studies. Am J Roentgenol 150: 189–197

    Google Scholar 

  2. DiChiro G, DeLa Paz RL, Brooks RA, et al (1982) Glucose utilization of cerebral gliomas measured by 18F-fluorodeoxyglucose and PET. Neurology 32: 1323–1329

    CAS  Google Scholar 

  3. Mazziotta JC (1991) The Continuing Challenge of Primary Brain Tumor Management: The Contribution of Positron Emission Tomography. Ann Neurology 29: 345–346

    Article  CAS  Google Scholar 

  4. Ito M, Lammertsma AA, Wise RJS, Bernardi S, Frackowiak RSJ, Heather JD, McKenzie CG, Thomas DGT, Jones T (1995) Measurement of Regional Cerebral Blood Flow and Oxygen Utilisation in Patients with Cerebral Tumours Using 150 and Positron Emission Tomography: Analytical Techniques and Preliminary Results Proocedings of the Society of Magnetic Resonance in Medicine, p. 394

    Google Scholar 

  5. Rosen BR, Belliveau JW, Vevea JM, Brady TJ (1990) Perfusion Imaging with NMR Contrast Agents. Magn Reson Med 14: 249–265

    Article  PubMed  CAS  Google Scholar 

  6. Rosen BR, Belliveau JW, Buchbinder BR, McKinstry RC, Porkka LM, Kennedy DN, Neuder MS, Fisel CR, Aronen HJ, Kwong KK, Weisskoff RM, Cohen MS, Brady TJ (1991) Contrast Agents and Cerebral Hemodynamics. Magn Reson Med 19: 285–292

    Article  PubMed  CAS  Google Scholar 

  7. Maeda M, Itoh S, Kimura H, Iwasaki T, Hayashi N, Yamamoto K, Ishii Y, Kubota T (in press) Tumor Vascularity in the Brain: Evaluation with Dynamic Susceptibility-Contrast MR Imaging. Magn Reson Med

    Google Scholar 

  8. Aronen HJ, Gazit IE, Louis DN, Buchbinder BR, Pardo FS, Weisskoff RM, Harsh GR, Cosgrove GR, Halpern EF, Hochberg FH, Rosen BR (1994) Cerebral Blood Volume Maps of Gliomas: Comparison with Tumor Grade and Histologic Findings. Radiology 191: 41–51

    Google Scholar 

  9. Rosen BR, Aronen HJ, Kwong KK, Belliveau JW, Hamberg LM, Fordham J (1993) Advances in Clinical Neuroimaging: Functional MR Imaging Techniques. RadioGraphics 13: 889–896

    Google Scholar 

  10. Rempp KA, Brix G, Wenz F, Becker CR, Gückel F, Lorenz WJ (1993) Quantification of Regional Cerebral Blood Flow and Volume with Dynamic Susceptibility Contrast-enhanced MR Imaging. Radiology 193: 637–641

    Google Scholar 

  11. Roberts TPL, Kucharczyk J, Cox I, Moseley ME, Prayer L, Dillon W, Bleyl K, Harnish P (1994) Sprodiamide-Injection-Enhanced Magnetic Resonance Imaging of Cerebral Perfusion. Invest Radiol 29: S24 - S26

    Article  PubMed  Google Scholar 

  12. Tzika AA, Massoth RJ, Ball, Jr WS, Majumdar S, Dunn RS, Kirks DR (1993) Cerebral Perfusion in Children: Detection with Dynamic Contrast-enhanced T2*-weighted MR Images. Radiology 187: 449–458

    PubMed  CAS  Google Scholar 

  13. Bahn MM (1995) A Single-Step Method for Estimation of Local Cerebral Blood Volume from Susceptibility Contrast MRI Images. Magn Reson Med 33: 309–317

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag Italia, Milano

About this paper

Cite this paper

Turski, P., Mock, B., Baker, E., Terae, S., Bahn, M. (1996). Tumor Viability Assessed by Cerebral Blood Volume Measurements. In: Pavone, P., Rossi, P. (eds) Functional MRI. Syllabus. Springer, Milano. https://doi.org/10.1007/978-88-470-2194-5_6

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-2194-5_6

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-3-540-75025-3

  • Online ISBN: 978-88-470-2194-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics